KR20080000621A - 항암 약물의 제조 방법 - Google Patents

항암 약물의 제조 방법 Download PDF

Info

Publication number
KR20080000621A
KR20080000621A KR1020077024768A KR20077024768A KR20080000621A KR 20080000621 A KR20080000621 A KR 20080000621A KR 1020077024768 A KR1020077024768 A KR 1020077024768A KR 20077024768 A KR20077024768 A KR 20077024768A KR 20080000621 A KR20080000621 A KR 20080000621A
Authority
KR
South Korea
Prior art keywords
toluene
solvent
temperature
mixture
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020077024768A
Other languages
English (en)
Korean (ko)
Inventor
마르꼬 빌라
로베르따 프레따
니꼴라 디울게로프
알레산드로 뽄띠롤리
Original Assignee
시코르, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 시코르, 인크. filed Critical 시코르, 인크.
Publication of KR20080000621A publication Critical patent/KR20080000621A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
KR1020077024768A 2005-04-06 2006-04-06 항암 약물의 제조 방법 Ceased KR20080000621A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US66913205P 2005-04-06 2005-04-06
US60/669,132 2005-04-06
US69452805P 2005-06-27 2005-06-27
US60/694,528 2005-06-27

Publications (1)

Publication Number Publication Date
KR20080000621A true KR20080000621A (ko) 2008-01-02

Family

ID=36694325

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077024768A Ceased KR20080000621A (ko) 2005-04-06 2006-04-06 항암 약물의 제조 방법

Country Status (8)

Country Link
US (2) US7692025B2 (https=)
EP (2) EP1751121A2 (https=)
JP (1) JP2008536836A (https=)
KR (1) KR20080000621A (https=)
CA (1) CA2601649A1 (https=)
IL (1) IL184944A0 (https=)
MX (1) MX2007012394A (https=)
WO (1) WO2006108155A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007012394A (es) * 2005-04-06 2007-11-07 Sicor Inc Procesos para la preparacion de farmacos anticancer.
EP2024343B1 (en) * 2006-05-19 2015-09-09 Synthon B.V. Process for purification of anastrozole
EP2029557A1 (en) 2006-06-05 2009-03-04 Cadila Healthcare Ltd. A process for preparing pure anastrozole
WO2008047104A1 (en) * 2006-10-17 2008-04-24 Cipla Limited Process for the preparation of pure anastrozole
WO2009010991A2 (en) * 2007-07-17 2009-01-22 Ind-Swift Laboratories Limited Purification process to prepare highly pure anastrozole
EP2343278A1 (en) 2010-01-07 2011-07-13 Hexal AG A process for preparing trisubstituted phenyl derivatives comprising a (1H-1,2,4-triazol-1-yl)alkyl group
CN106083748B (zh) * 2016-06-21 2019-08-16 扬子江药业集团江苏海慈生物药业有限公司 一种阿那曲唑的制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714013D0 (en) 1987-06-16 1987-07-22 Ici Plc (substituted-aralkyl)heterocyclic compounds
JPH07138234A (ja) * 1993-11-11 1995-05-30 Kureha Chem Ind Co Ltd アゾリルメチルシクロアルカノール誘導体の製造方法
EP1165512A2 (de) * 1999-03-30 2002-01-02 Gödecke Gmbh Verfahren zur herstellung von n-aryl-aza-heterocyclen in gegenwart von cesiumcarbonat
US8436029B2 (en) 2004-03-19 2013-05-07 Transform Pharmaceuticals, Inc. Pharmaceutical forms, and methods of making and using the same
WO2005105762A1 (en) 2004-05-05 2005-11-10 Natco Pharma Limited Improved process for the preparation of high purity anastrozole
GB0412492D0 (en) * 2004-06-04 2004-07-07 Sterix Ltd Compound
US20060035950A1 (en) * 2004-08-09 2006-02-16 Mohammed Alnabari Novel processes for preparing substantially pure anastrozole
US20060189670A1 (en) 2005-02-22 2006-08-24 Glenmark Pharmaceuticals Limited Process for the preparation of anastrozole and intermediates thereof
EP1705168A1 (en) * 2005-03-21 2006-09-27 Helm AG Improved process for side-chain bromination of alkyl-benzenes
MX2007012394A (es) * 2005-04-06 2007-11-07 Sicor Inc Procesos para la preparacion de farmacos anticancer.
CN101208312A (zh) 2005-06-27 2008-06-25 西科尔公司 用于合成阿那曲唑及纯化一种阿那曲唑中间体的方法
US20090221837A1 (en) 2005-09-30 2009-09-03 Kirtipalsinh Saijansinh Solanki Process for the Preparation of Pure Anastrozole
WO2007039913A1 (en) * 2005-10-05 2007-04-12 Usv Limited Process for the preparation of 2,2’-[5-(1,2,4-triazole-1-ylmethyl) -1,3-phenylene] di (2-methylpropionitrile).
WO2007039919A1 (en) 2005-10-06 2007-04-12 Natco Pharma Limited Crystalline forms of anastrozole
US20070100148A1 (en) 2005-10-31 2007-05-03 Veerender Murki Process for preparing anastrozole
EP1994014A4 (en) 2006-03-10 2010-01-20 Shilpa Medicare Ltd IMPROVED PROCESS FOR HIGH-PURITY ANASTROZOL
EP2024343B1 (en) 2006-05-19 2015-09-09 Synthon B.V. Process for purification of anastrozole
EP2029557A1 (en) 2006-06-05 2009-03-04 Cadila Healthcare Ltd. A process for preparing pure anastrozole
FR2904821B1 (fr) 2006-08-09 2009-02-20 Air Liquide Procede de purification d'hydrogene
WO2008034644A2 (en) 2006-09-22 2008-03-27 Synthon B.V. Process for making anastrozole
WO2008047104A1 (en) 2006-10-17 2008-04-24 Cipla Limited Process for the preparation of pure anastrozole
US20080177081A1 (en) * 2007-01-19 2008-07-24 Formosa Laboratories, Inc. Process for Preparation of Anastrozole

Also Published As

Publication number Publication date
EP2172449A2 (en) 2010-04-07
US7692025B2 (en) 2010-04-06
IL184944A0 (en) 2007-12-03
US20100099888A1 (en) 2010-04-22
WO2006108155A2 (en) 2006-10-12
MX2007012394A (es) 2007-11-07
JP2008536836A (ja) 2008-09-11
EP1751121A2 (en) 2007-02-14
US20060276657A1 (en) 2006-12-07
EP2172449A3 (en) 2011-06-22
CA2601649A1 (en) 2006-10-12
WO2006108155A3 (en) 2006-11-23

Similar Documents

Publication Publication Date Title
EP2024343B1 (en) Process for purification of anastrozole
US20100099888A1 (en) Process for the preparation of anticancer drugs
KR100917698B1 (ko) 레트로졸의 제조를 위한 개선된 방법
WO2004076409A2 (en) Regiospecific process for the preparation of 4-[1- (4-cyanophenyl)-1-(1,2,4-triazol-1-yl)methyl]benzonitrile
KR101502322B1 (ko) 순수한 아나스트로졸의 제조방법
EP2678333B1 (en) An improved process for the preparation of voriconazole and intermediates thereof
CA3059394C (en) Preparation of 2-([1,2,3]triazol-2-yl)-benzoic acid derivatives
CN101208312A (zh) 用于合成阿那曲唑及纯化一种阿那曲唑中间体的方法
EP3762359B1 (en) Method for preparation of 2-chloroacetoacetic acid amide and ester
CA2433720A1 (en) An improved process for preparing pure ondansetron hydrochloride dihydrate
CN113651762B (zh) 一种1-甲基-1h-1,2,4-三氮唑-3-甲酸甲酯的制备方法
US20090118517A1 (en) Purification process for anastrozole intermediate
WO2022191139A1 (ja) ３－ブロモ－１－（３－クロロピリジン－２－イル）－１ｈ－ピラゾール－５－カルボン酸エステルの製造方法
WO2023100110A1 (en) Process for preparing brivaracetam
EP2456758B1 (en) A process for preparing trisubstituted phenyl derivatives comprising a (1h-1,2,4-triazol-1-yl)alkyl group
JPS5922710B2 (ja) １−アルキル−３−ヒドロキシ−５−クロロ−１，２，４−トリアゾ−ルの製造方法
EP2518057A1 (en) Process for the purification of rufinamide
HK40036616A (en) Method for preparation of 2-chloroacetoacetic acid amide and ester
HK40036616B (en) Method for preparation of 2-chloroacetoacetic acid amide and ester
JPS58216166A (ja) Ｎ−置換イミダゾ−ル類の製造法
WO2009109222A1 (en) Process for the preparation of rimonabant
WO2014184754A1 (en) Method for preparing anastrozole for pharmaceutical purposes

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

R18 Changes to party contact information recorded

Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R18-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000